Healthcare reform act includes gift ban mandates
March 29, 2010 by MassDevice staff
The healthcare reform act includes provisions covering industry payments to physicians requiring companies to report any gifts or payments worth more than $10.
The healthcare reform act contains stringent rules mandating the public disclosure of gifts and payments made to doctors by medical device, pharmaceutical and biotech companies.
The so-called "Physician Payments Sunshine Provision" of the Health Care and Education Reconciliation Act of 2010 requires the companies to begin reporting gifts or payments worth more than $10 no later than March 31, 2013. The result, a searchable database containing the names and addresses of each recipient and the details of the payments, will be made publicly available by Sept. 30 of that year, and on June 30 every year following.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
Navigation
NEWS
Medical device tax: Consultant calls offshoring concerns 'horse hockey'
Concerns that the medical device tax will push companies to lay off workers and move operations...
FDA clears OrthoSensor's Verasense knee replacement device
The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement...
ArtVentive Medical wins CE Mark for peripheral catheter
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
Recalls: FDA makes Endologix catheter introducer recall Class I
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
pSivida gains big on buyout rumor
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...
